All publications

Proposed addendum to the 2006 US Food and Drug Administration guidance on chronic cutaneous ulcers and burn wounds: wound research endpoints and clinical trial design

The Wound Care Collaborative Community proposes modernizing the 2006 FDA guidance with standardized preclinical reporting, digital wound assessment, biomarkers, innovative trial designs, and validated alternative and patient-reported endpoints while retaining complete closure as the principal endpoint.

Principal reported finding

What the publication reports

The Wound Care Collaborative Community proposes modernizing the 2006 FDA guidance with standardized preclinical reporting, digital wound assessment, biomarkers, innovative trial designs, and validated alternative and patient-reported endpoints while retaining complete closure as the principal endpoint.

Study context

Evidence should be read with its design.

Study type
Field leadership / trial-design perspective
Publication date
Journal
Wounds 38(6):155–165

Interpretation

This field-leadership perspective contributes to the discussion of wound-study endpoints and trial design; it is not product-efficacy evidence.